News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Photos of Marc Machaalani, Nazli Dizman, Emre Yekedüz and Toni Choueiri
May 25, 2024, 14:20

Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC

Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on X and added:

“Just in ASCO Daily News where Nazli Dizman, Emre Yekedüz, and I briefly discuss immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC, under the mentorship of Toni Choueiri!”

Quoting ASCO‘s post:

“For ASCO Daily News, Toni Choueiri, Nazli Dizman, Marc Machaalani, and Emre Yekedüz examine recent/ongoing research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC.”

Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC

Source: Marc Machaalani/X and ASCO/X

ASCO ASCO Daily News cancer cancer immunotherapy Dana-Farber Cancer Institute Emre Yekedüz immune checkpoint inhibition immunotherapy Marc Machaalani mRCC Nazli Dizman OncoDaily Oncology renal cell cancer Toni Choueiri
Special Coverage
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been